Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,286	1,664	2,315	4,630	9,198	5,020
Market Cap Growth	227.78%	-28.11%	-50.00%	-49.66%	83.22%	89.41%
Enterprise Value	7,254	2,970	4,280	5,812	10,967	5,857
Last Close Price	3.89	2.43	3.38	6.76	13.43	7.33
PE Ratio	-	-	-	-	-	240.13
PS Ratio	12.88	4.82	8.10	6.80	36.98	42.15
PB Ratio	-151.42	6.93	7.57	5.18	8.65	3.94
P/TBV Ratio	-	357.62	93.19	8.42	12.81	5.56
P/OCF Ratio	-	-	99.98	87.12	-	-
EV/Sales Ratio	14.86	8.60	14.98	8.53	44.09	49.17
EV/EBITDA Ratio	-	-	-	165.68	-	15473.67
EV/FCF Ratio	-19.91	-	-	-	-	-
Debt / Equity Ratio	-20.21	2.82	5.57	1.81	1.41	1.06
Debt / EBITDA Ratio	-	-	-	45.58	-	3559.90
Net Debt / Equity Ratio	-20.01	2.78	5.49	1.71	1.31	0.90
Net Debt / EBITDA Ratio	-3.98	-7.64	-25.99	43.49	-9.87	3012.39
Net Debt / FCF Ratio	-2.28	-7.32	-48.63	-247.43	-5.38	-1.47
Asset Turnover	0.22	0.14	0.09	0.21	0.08	0.04
Inventory Turnover	5.51	4.84	4.09	4.99	3.45	1.26
Quick Ratio	0.07	0.04	0.05	0.08	0.12	0.45
Current Ratio	0.16	0.11	0.11	0.16	0.29	0.63
Return on Equity (ROE)	-	-211.44%	-85.90%	-17.38%	-16.21%	2.11%
Return on Assets (ROA)	-9.23%	-5.23%	-4.05%	-1.66%	-3.77%	-0.32%
Return on Invested Capital (ROIC)	-37.76%	-14.83%	-9.18%	-3.59%	-8.23%	-0.66%
Return on Capital Employed (ROCE)	-142.00%	-79.60%	-18.80%	-5.10%	-9.00%	-0.60%
Earnings Yield	-4.94%	-32.38%	-20.08%	-3.06%	-1.81%	0.42%
FCF Yield	-5.80%	-5.49%	-1.49%	-0.13%	-2.81%	-15.42%
Payout Ratio	-	-	-	-	-	223.58%
Buyback Yield / Dilution	-0.00%	-0.05%	-0.13%	-0.00%	-1.35%	0.98%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.